Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
13F holders, Q1 2024
Institutional positions in Silence Therapeutics plc as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 64
- +30 vs. Q4 2023
- Shares held
- 27.7M
- +7.18M (+35.0%) vs. Q4 2023
- Total value
- $588.0M
- +$244.1M (+71.0%) vs. Q4 2023
- New holders
- 32
- 17 more added
- Sold out
- 2
- 11 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 72 | $236.2M |
| Q1 2026 | 56 | $102.1M |
| Q4 2025 | 58 | $106.1M |
| Q3 2025 | 54 | $96.4M |
| Q2 2025 | 55 | $108.0M |
| Q1 2025 | 59 | $60.6M |
| Q4 2024 | 65 | $168.2M |
| Q3 2024 | 69 | $493.1M |
| Q2 2024 | 71 | $502.1M |
| Q1 2024 | 64 | $588.0M |
| Q4 2023 | 34 | $343.9M |
| Q3 2023 | 28 | $187.6M |
| Q2 2023 | 29 | $101.8M |
| Q1 2023 | 29 | $110.2M |
| Q4 2022 | 27 | $275.7M |
| Q3 2022 | 29 | $183.4M |
| Q2 2022 | 25 | $116.4M |
| Q1 2022 | 26 | $218.3M |
| Q4 2021 | 22 | $246.6M |
| Q3 2021 | 7 | $39.4M |
| Q2 2021 | 6 | $56.4M |
| Q1 2021 | 6 | $55.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Silence Therapeutics plc; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCG Crossover Management, LLC | 3,295,350 | $71.2M | 5.63% | +1,190,475+56.6% | Added |
| Artal Group S.A. | 2,779,619 | $60.0M | 1.55% | −220,381−7.3% | Reduced |
| Lombard Odier Asset Management (Europe) Ltd | 2,238,039 | $48.3M | 3.08% | −1,374,838−38.1% | Reduced |
| Redmile Group, LLC | 2,027,669 | $43.8M | 1.61% | +2,027,669 | New |
| Lombard Odier Asset Management (USA) Corp | 2,388,912 | $41.6M | 5.99% | −1,490,261−38.4% | Reduced |
| Deep Track Capital, LP | 1,643,881 | $35.5M | 1.02% | −307,699−15.8% | Reduced |
| Logos Global Management LP | 1,476,061 | $31.1M | 3.27% | +1,076,061+269.0% | Added |
| Frazier Life Sciences Management, L.P. | 1,148,591 | $24.8M | 1.05% | +267,418+30.3% | Added |
| Vivo Capital, LLC | 1,105,454 | $23.9M | 1.88% | +595,250+116.7% | Added |
| Nextech Invest AG | 952,400 | $20.6M | 3.26% | +952,400 | New |
| Janus Henderson Group PLC | 625,864 | $13.6M | 0.01% | +625,864 | New |
| Cormorant Asset Management, LP | 625,000 | $13.5M | 0.59% | +625,000 | New |
| Adage Capital Partners GP, L.L.C. | 600,000 | $13.0M | 0.02% | +600,000 | New |
| Aquilo Capital Management, LLC | 574,214 | $12.4M | 9.30% | −469,070−45.0% | Reduced |
| Lynx1 Capital Management LP | 526,642 | $11.4M | 2.93% | +290,855+123.4% | Added |
| Polar Capital Holdings Plc | 500,000 | $10.8M | 0.07% | +500,000 | New |
| 5AM Venture Management, LLC | 476,200 | $10.3M | 2.30% | +476,200 | New |
| Millennium Management LLC | 409,418 | $8.84M | 0.01% | +409,418 | New |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 387,400 | $8.37M | 0.22% | +387,400 | New |
| Mangrove Partners | 385,408 | $8.32M | 0.72% | +385,408 | New |
| Octagon Capital Advisors LP | 315,000 | $6.80M | 0.83% | +315,000 | New |
| M28 Capital Management LP | 299,400 | $6.47M | 4.78% | −64,400−17.7% | Reduced |
| Hudson Bay Capital Management LP | 276,590 | $5.97M | 0.05% | +276,590 | New |
| Parkman Healthcare Partners LLC | 244,471 | $5.28M | 0.65% | +11,529+4.9% | Added |
| Morgan Stanley | 242,770 | $5.24M | 0.00% | +179,962+286.5% | Added |
| Woodline Partners LP | 238,380 | $5.15M | 0.05% | +189,108+383.8% | Added |
| Nantahala Capital Management, LLC | 200,000 | $4.32M | 0.42% | +200,000 | New |
| HSBC Holdings PLC | 177,834 | $3.84M | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 139,191 | $3.01M | 0.00% | +139,191 | New |
| Schonfeld Strategic Advisors LLC | 133,000 | $2.87M | 0.02% | +83,800+170.3% | Added |
| Boothbay Fund Management, LLC | 127,224 | $2.75M | 0.08% | +127,224 | New |
| Two Sigma Investments, LP | 107,212 | $2.32M | 0.01% | +107,212 | New |
| Renaissance Technologies LLC | 103,900 | $2.24M | 0.00% | +76,798+283.4% | Added |
| Cantor Fitzgerald, L. P. | 103,483 | $2.24M | 0.53% | −43,294−29.5% | Reduced |
| Walleye Capital LLC | 91,819 | $1.98M | 0.02% | +91,819 | New |
| BIT Capital GmbH | 89,000 | $1.92M | 0.17% | +89,000 | New |
| Two Sigma Advisers, LP | 77,400 | $1.67M | 0.00% | +77,400 | New |
| UBS Oconnor LLC | 72,223 | $1.56M | 0.04% | −20,975−22.5% | Reduced |
| UBS Group AG | 71,918 | $1.55M | 0.00% | +1,972+2.8% | Added |
| Citigroup Inc | 58,333 | $1.26M | 0.00% | 00.0% | Unchanged |
| Artia Global Partners LP | 52,476 | $1.13M | 0.28% | +52,476 | New |
| Citadel Advisors LLC | 42,682 | $921.9K | 0.00% | +20,945+96.4% | Added |
| ADAR1 Capital Management, LLC | 40,090 | $865.9K | 0.24% | +39,900+21,000.0% | Added |
| Cubist Systematic Strategies, LLC | 36,281 | $783.7K | 0.01% | +36,281 | New |
| Blair William & Co | 25,432 | $549.3K | 0.00% | −116−0.5% | Reduced |
| Geode Capital Management, LLC | 22,427 | $484.4K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 21,739 | $469.6K | 0.00% | +21,739 | New |
| Trexquant Investment LP | 21,047 | $454.6K | 0.01% | +21,047 | New |
| Rathbone Brothers plc | 19,906 | $430.0K | 0.00% | +19,906 | New |
| Jump Financial, LLC | 18,800 | $406.1K | 0.01% | +18,800 | New |
| Shay Capital LLC | 15,150 | $327.2K | 0.10% | +15,150 | New |
| Bank of America Corp | 11,992 | $259.0K | 0.00% | +10,916+1,014.5% | Added |
| NEOS Investment Management LLC | 11,656 | $251.8K | 0.02% | +11,656 | New |
| Advisor Group Holdings, Inc. | 10,922 | $235.8K | 0.00% | +10,922 | New |
| JPMorgan Chase & Co | 9,610 | $207.6K | 0.00% | +9,610 | New |
| Point72 Asset Management, L.P. | 8,200 | $177.1K | 0.00% | +8,200 | New |
| SG Americas Securities, LLC | 7,000 | $151.0K | 0.00% | +667+10.5% | Added |
| Barclays PLC | 5,570 | $120.3K | 0.00% | +5,570 | New |
| Qube Research & Technologies Ltd | 3,942 | $85.1K | 0.00% | +3,764+2,114.6% | Added |
| Lazard Asset Management LLC | 1,415 | $29.0K | 0.00% | −855−37.7% | Reduced |
| Advisors Preferred, LLC | 1,109 | $24.1K | 0.00% | +1,109 | New |
| GAMMA Investing LLC | 876 | $18.9K | 0.00% | −42−4.6% | Reduced |
| Steward Partners Investment Advisory, LLC | 100 | $2.16K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 15 | $324 | 0.00% | +10+200.0% | Added |
| BVF Inc | 0 | $0 | 0.00% | −1,508,416−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −707−100.0% | Sold out |